Cancer medicines
Durvalumab
Durvalumab
An immunotherapy used in selected lung and biliary tract cancers and other settings.
Sources checked · Introductory guide
On this page
How it works
It blocks PD-L1 to help the immune system attack cancer cells.[2]
Where it is used
Use in lung cancer depends on stage and prior treatment; in advanced biliary tract cancer it is combined with specific chemotherapy.[1]
Key safety points
Report new cough, breathlessness, diarrhea or jaundice immediately. Discuss autoimmune disease and prior chest radiation before treatment.[2]
Questions for your care team
- What is its role at this treatment stage, and which symptoms should I watch for?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.